Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-21-101663

Chief Medical Officer acquired 725 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2021-07-31 Grant or award +725 $7.71 $5,589 5,762 D
Loading xslF345X03/tm2124283-3_4seq1.xml…